Evidence map›Paper›PMID 35681456›Full record

ReviewCells2022

A Nuclear Belt Fastens on Neural Cell Fate.

Ivan Mestres, Judith Houtman, Federico Calegari, Tomohisa Toda

Abstract readReview
In one paragraph

Review in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ivan MestresCenter for Molecular and Cellular Bioengineering (CMCB), DFG-Center for Regenerative Therapies Dresden, Technische Universität Dresden, Fetscherstr. 105, 01307 Dresden, Germany.ORCID 0000-0001-6793-9547
Judith HoutmanNuclear Architecture in Neural Plasticity and Aging, German Center for Neurodegenerative Diseases (DZNE), Tatzberg 41, 01307 Dresden, Germany.
Federico CalegariCenter for Molecular and Cellular Bioengineering (CMCB), DFG-Center for Regenerative Therapies Dresden, Technische Universität Dresden, Fetscherstr. 105, 01307 Dresden, Germany.
Tomohisa TodaNuclear Architecture in Neural Plasticity and Aging, German Center for Neurodegenerative Diseases (DZNE), Tatzberg 41, 01307 Dresden, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Successful embryonic and adult neurogenesis require proliferating neural stem and progenitor cells that are intrinsically and extrinsically guided into a neuronal fate. In turn, migration of new-born neurons underlies the complex cytoarchitecture of the brain. Proliferation and migration are therefore essential for brain development, homeostasis and function in adulthood. Among several tightly regulated processes involved in brain formation and function, recent evidence points to the nuclear envelope (NE) and NE-associated components as critical new contributors. Classically, the NE was thought to merely represent a barrier mediating selective exchange between the cytoplasm and nucleoplasm. However, research over the past two decades has highlighted more sophisticated and diverse roles for NE components in progenitor fate choice and migration of their progeny by tuning gene expression via interactions with chromatin, transcription factors and epigenetic factors. Defects in NE components lead to neurodevelopmental impairments, whereas age-related changes in NE components are proposed to influence neurodegenerative diseases. Thus, understanding the roles of NE components in brain development, maintenance and aging is likely to reveal new pathophysiological mechanisms for intervention. Here, we review recent findings for the previously underrepresented contribution of the NE in neuronal commitment and migration, and envision future avenues for investigation.

Indexed as

NeurogenesisNeuronsCell DifferentiationCell NucleusNuclear Envelopeagingchromatin regulationdevelopmentneurogenesisneuronal migrationnuclear envelope

Identifiers

PMID35681456
PMCPMC9179901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.